Stay updated with breaking news from Jeffrey Silber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VE303 is an orally administered, potential first-in-class live biotherapeutic product candidate being developed to prevent recurrence of Clostridioides difficile infection ...
Investegate announcements from PRTC's Vedanta Begins Phase 3 of VE303 in C. diff
PureTech Health PLC on Tuesday said that a company it founded and in which it maintains a stake had begun trials of a new treatment for clostridioides difficile infection, in the hopes of moving...
In the preceding three months, 5 analysts have released ratings for Strategic Education (NASDAQ:STRA), presenting a wide array of perspectives fro...
In this article we will be taking a look at the 16 best financial stocks to buy according to hedge funds.